Send to:

Choose Destination
See comment in PubMed Commons below
Beijing Da Xue Xue Bao. 2011 Aug 18;43(4):632-5.

[Treatments of erectile dysfunction combined with lower urinary tract symptoms associated with benign prostatic hyperplasis].

[Article in Chinese]

Author information

  • 1Andrology Center, Peking University First Hospital, Beijing 100034, China.


Lower urinary tract symptoms secondary to benign prostatic hyperplasia (BPH/LUTS) and erectile dysfunction (ED) are common conditions seen in aging males. Although the exact mechanism of ED combined BPH/LUTS is unknown, treatment with α-adrenergic receptor resistance agents (α-ARAs) contributes to some improvement in ED, and phosphodiesterase-5 inhibitors (PDE-5I) are also of benefit to BPH/LUTS. The action mechanisms of these medications support these observed benefits, which are being studied in the basic science and clinical settings. Much remains to be investigated, but it is clear that the associations between BPH/LUTS and ED lay the foundation for future therapies and possible preventative strategies. This article has mainly summarized the advancement of epidemiology, basic research and treatment of ED combined with BPH/LUTS with α-receptor blockers and phosphodiesterase-5 inhibitors.

[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Journal of Peking University (Health Sciences)
    Loading ...
    Write to the Help Desk